C. Guo

发表

A rapid, semiautomated method for apolipoprotein E genotyping.

P. Marynen, J. Cassiman, C. Guo, 1993, PCR methods and applications.

TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13).

P. Marynen, A. Aventín, C. Mecucci, 1995, Blood.

Comprehensive analysis of chromosome 1p deletions in neuroblastoma.

D. Stram, J. Maris, K. Matthay, 2001, Medical and pediatric oncology.

Deletion of 11q23 is a frequent event in the evolution of MYCN single-copy high-risk neuroblastomas.

D. Stram, J. Maris, R. Gerbing, 2000, Medical and pediatric oncology.

Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.

D. Stram, J. Maris, K. Matthay, 2001, Medical and pediatric oncology.

Confirmation of the novel association at the BTNL2 locus with ulcerative colitis.

J. Barrett, D. Jewell, A. Morris, 2009, Tissue antigens.

Single nucleotide polymorphisms near the inhibin beta B gene on 2q14 are associated with pre-eclampsia in Han Chinese women.

Q. Wang, X. Wang, Y. Yang, 2015, European journal of obstetrics, gynecology, and reproductive biology.

The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia.

P. Marynen, Caiying Guo, H. Cavé, 1996, Blood.

Loss of heterozygosity for chromosome 14q in neuroblastoma.

T. Matise, D. Stram, J. Maris, 2001, Medical and pediatric oncology.

Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele.

P. Marynen, K. Devriendt, J. Cassiman, 1995, The Journal of clinical investigation.

Differential splicing of COL4A5 mRNA in kidney and white blood cells: a complex mutation in the COL4A5 gene of an Alport patient deletes the NC1 domain.

P. Marynen, J. Cassiman, H. Berghe, 1993 .

Genomic organization of TEL: the human ETS-variant gene 6.

P. Marynen, J. Aerssens, M. Baens, 1996, Genome research.

The genetics of NOD-like receptors in Crohn's disease.

L. Cardon, D. Jewell, G. Clarke, 2010, Tissue antigens.

Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.

D. Stram, J. Maris, K. Matthay, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of caspase-9 and RUNX3 with inflammatory bowel disease.

D. Jewell, Tariq Ahmad, S. Pathan, 2011, Tissue antigens.

Detailed molecular analysis of 1p36 in neuroblastoma.

T. Matise, S. Gregory, J. Biegel, 2001, Medical and pediatric oncology.

Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas.

J. Maris, E. Sulman, P. White, 2000, Medical and pediatric oncology.

Analysis of genomic imprinting at 1p35-36 in neuroblastoma.

J. Maris, P. White, M. Hogarty, 2001, Medical and pediatric oncology.

Characterizing Associations and SNP-Environment Interactions for GWAS-Identified Prostate Cancer Risk Markers—Results from BPC3

Peter Kraft, Jing Ma, Mattias Johansson, 2011, PloS one.

Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13.

M. Urbanek, T. Rebbeck, J. Maris, 2000, Medical and pediatric oncology.

A physical map of the region spanning the chromosome 12 translocation breakpoint in a mesothelioma with a t(X;12)(q22;p13).

J. Vermeesch, J. Aerssens, M. Litt, 1995, Cytogenetics and cell genetics.